- Home
- PHGE vs LVLU Comparison
PHGE vs LVLU Comparison
Compare PHGE & LVLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- LVLU
- Stock Information
- Founded
- PHGE 2015
- LVLU 1996
- Country
- PHGE Israel
- LVLU United States
- Employees
- PHGE N/A
- LVLU N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- LVLU Catalog/Specialty Distribution
- Sector
- PHGE Health Care
- LVLU Consumer Discretionary
- Exchange
- PHGE Nasdaq
- LVLU Nasdaq
- Market Cap
- PHGE 10.4M
- LVLU 10.8M
- IPO Year
- PHGE N/A
- LVLU 2021
- Fundamental
- Price
- PHGE $0.52
- LVLU $3.95
- Analyst Decision
- PHGE Strong Buy
- LVLU Hold
- Analyst Count
- PHGE 1
- LVLU 1
- Target Price
- PHGE $15.00
- LVLU $15.00
- AVG Volume (30 Days)
- PHGE 991.6K
- LVLU 40.0K
- Earning Date
- PHGE 08-13-2025
- LVLU 08-13-2025
- Dividend Yield
- PHGE N/A
- LVLU N/A
- EPS Growth
- PHGE N/A
- LVLU N/A
- EPS
- PHGE N/A
- LVLU N/A
- Revenue
- PHGE N/A
- LVLU $292,337,000.00
- Revenue This Year
- PHGE N/A
- LVLU N/A
- Revenue Next Year
- PHGE N/A
- LVLU $2.53
- P/E Ratio
- PHGE N/A
- LVLU N/A
- Revenue Growth
- PHGE N/A
- LVLU N/A
- 52 Week Low
- PHGE $0.34
- LVLU $2.98
- 52 Week High
- PHGE $1.23
- LVLU $28.05
- Technical
- Relative Strength Index (RSI)
- PHGE 50.56
- LVLU 47.01
- Support Level
- PHGE $0.49
- LVLU $3.67
- Resistance Level
- PHGE $0.56
- LVLU $4.70
- Average True Range (ATR)
- PHGE 0.04
- LVLU 0.35
- MACD
- PHGE -0.01
- LVLU -0.00
- Stochastic Oscillator
- PHGE 49.28
- LVLU 26.80
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
About LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.